Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» China
China
Bristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA
Fierce Pharma
Tue, 02/2/21 - 11:15 pm
Bristol-Myers Squibb
CDMO
China
WuXi Biologics
ISTA Pharmaceuticals
Illumina Partners with Sequoia Capital for its 3rd Life Science Incubator, This One in China
BioSpace
Tue, 02/2/21 - 11:07 pm
Illumina
Sequoia
incubators
China
Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up
Fierce Biotech
Fri, 01/15/21 - 09:43 am
Sinopharm
China
COVID-19
vaccines
pediatric
Fast-expanding Shanghai Pharma breaks ground on $1.8B biotech park focused on next-gen R&D, antibody production
Endpoints
Mon, 01/4/21 - 10:23 am
China
Shanghai Pharmaceutical
R&D
Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?
Fierce Biotech
Sun, 01/3/21 - 04:29 pm
China
COVID-19
Gilead Sciences
remdesivir
Folotyn
Acrotech Biopharma
China’s Sinopharm Claims COVID-19 Vaccine has 79% Efficacy
BioSpace
Sun, 01/3/21 - 04:16 pm
Sinopharm
China
COVID-19
vaccines
clinical trials
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Fierce Pharma
Wed, 12/30/20 - 10:53 am
Merck
Bristol-Myers Squibb
AstraZeneca
Roche
Keytruda
Opdivo
Imfinzi
Tecentriq
China
PD-1 inhibitors
Allogene, broadening its reach, helps start a new biotech in China
BioPharma Dive
Tue, 12/15/20 - 10:47 am
Allogene
Overland Pharmaceuticals
China
cell therapies
Allogene Overland Pharma
BioNTech, Fosun start COVID-19 vaccine trial to support Chinese approval
Fierce Biotech
Wed, 11/25/20 - 10:31 am
BioNTech
Fosun Pharmaceutical
China
clinical trials
vaccines
COVID-19
Pfizer hands LianBio $70M to tag along Perceptive's China play, with an eye to beefing up regional portfolio
Endpoints
Thu, 11/19/20 - 08:33 pm
China
Pfizer
Perceptive Advisors
LianBio
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
Endpoints
Wed, 11/4/20 - 10:30 am
JW Therapeutics
IPOs
CAR-T
liso-cel
China
Hong Kong
Juno Therapeutics
WuXi AppTec
Biden And Trump Drug Pricing Policies Would Decimate Biotech, Drive Innovation To China
Forbes
Fri, 10/23/20 - 10:59 am
Joe Biden
Donald Trump
2020 Presidential election
drug pricing
innovation
pharma industry
China
FDA reissues Chinese respirator EUA, but freezes new additions
RAPS.org
Sun, 10/18/20 - 08:36 pm
FDA
China
devices
Emergency Use Authorization
COVID-19
Pfizer infuses $200M into CStone, scoring a second PD-L1 and outlining a sprawling China pact
Endpoints
Wed, 09/30/20 - 10:37 am
Pfizer
China
CStone
cancer
Racing ahead of Merck and Innovent, Junshi declares PhIII success on cancer that won them 'breakthrough' status
Endpoints
Tue, 09/29/20 - 11:51 am
Junshi Biosciences
China
Merck
Innovent
nasopharyngeal carcinoma
toripalimab
China’s Junshi hits immuno-oncology milestone with breakthrough designation from FDA
MedCity News
Sat, 09/12/20 - 10:22 pm
China
Junshi Biosciences
immuno-oncology
toripalimab
nasopharyngeal carcinoma
FDA
Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme
Pharmafile
Tue, 09/8/20 - 10:32 pm
China
vaccines
COVID-19
Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi
Endpoints
Fri, 08/21/20 - 12:45 pm
Eli Lilly
Lilly Asia Ventures
AstraZeneca
China
R&D
Dizal Pharmaceutical
How Is Medtech Impacted by a Strained US-China Relationship? A CEO Speaks Out
Medical Devices and Diagnostics Industry
Thu, 08/20/20 - 10:36 am
China
devices
Medtech
Todos Medical
Eli Lilly Strikes $1 Billion Deal with Innovent for Checkpoint Inhibitor
BioSpace
Tue, 08/18/20 - 11:00 pm
Eli Lilly
Innovent Biologics
China
immuno-oncology
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »